Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

DGX
Quest Diagnostics Inc.
stock NYSE

Market Open
Jan 14, 2026 9:30:03 AM EST
180.42USD+0.256%(+0.46)10
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jan 12, 2026 8:26:30 AM EST
174.44USD-0.853%(-1.50)0
After-hours
Jan 13, 2026 4:00:30 PM EST
179.96USD-0.061%(-0.11)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
07:27AM EST  Quest Diagnostics (DGX) said they will now offer consumer-initiated laboratory testing powered by QuestDirect through Walmart.com. The new testing solution allows an individual to purchase among more than 50 different tests, including general health, digestive health, allergy, heart health, women's health, and infectious disease.   RTTNews
07:11AM EST  Quest Diagnostics Announces That The Co. Will Now Offer Consumer-initiated Laboratory Testing Powered By QuestDirect In Collaboration With Walmart   Benzinga
07:04AM EST  Quest To Offer Consumer-initiated Laboratory Testing Powered By QuestDirect In Collaboration With Walmart   RTTNews
07:01AM EST  Healthcare Through New Consumer-Initiated Laboratory Testing Solution Powered by QuestDirect(tm) Through Walmart.com   PR Newswire
Jan 28, 2022
12:45PM EST  Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's   PR Newswire
10:17AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2022   Benzinga
10:16AM EST  Where Quest Diagnostics Stands With Analysts   Benzinga
09:25AM EST  Deutsche Bank Downgrades Quest Diagnostics to Hold, Announces $129 Price Target   Benzinga
Jan 26, 2022
07:07AM EST  Quest Diagnostics Launches COVID-19 Rapid Antigen Test Through QuestDirect   Benzinga
07:05AM EST  Quest Diagnostics: COVID-19 Rapid Antigen Test Launched With Observed Collection For Consumers Through QuestDirect   RTTNews
07:02AM EST  Quest Diagnostics Launches COVID-19 Rapid Antigen Test with Observed Collection   PR Newswire
Jan 19, 2022
07:15AM EST  Quest Diagnostics Launches Virtual Preventive Care Service Through QuestDirect   Benzinga
07:01AM EST  Quest Diagnostics Launches Virtual Preventive Care Service Through   PR Newswire
Jan 18, 2022
07:36AM EST  Quest Diagnostics To Acquire Pack Health; No Terms Disclosed   Benzinga
07:14AM EST  Quest Diagnostics (DGX) has entered into a definitive agreement to acquire Pack Health in an all-cash equity deal. Pack Health is a patient-engagement company that helps individuals adopt healthier behaviors to improve outcomes. The financial terms of the deal were not disclosed.   RTTNews
07:10AM EST  Quest Diagnostics Agrees To Acquire Pack Health For Undisclosed Financial Terms   RTTNews
07:05AM EST  Quest Diagnostics to Acquire Patient-Engagement Company Pack Health to Improve   PR Newswire
Jan 14, 2022
02:32PM EST  White House Official Says May Purchase More Than 1B At-Home Tests; Says 'We're Not Stopping There;' Orders Will Be Limited To 4 Tests Per Residential Address; Tests Will Ship Within 7-12 Days Of Ordering   Benzinga
Jan 13, 2022
11:50AM EST  Monday Is Your Last Chance To Buy Quest Diagnostics Before The Dividend Payout   Benzinga
Jan 12, 2022
10:05AM EST  Quest Diagnostics Inc. (DGX) shares are declining on Wednesday morning trade after the company said it expects fourth-quarter revenue and earnings per share to decline from the previous year.   RTTNews
07:25AM EST  Ahead of its virtual presentation at the 40th Annual J.P. Morgan Healthcare Conference later on Wednesday, Quest Diagnostics Inc. (DGX) announced preliminary financial results for the fourth quarter and full year 2021.   RTTNews
06:52AM EST  Quest Diagnostics Sees FY22 Adj. EPS $7.40-$8.00 vs $8.94 Est., Sales $8.5B vs $9.13B Est.   Benzinga
06:51AM EST  Quest Diagnostics Sees Prelim. Q4 Sales $2.74B vs $2.54B Est., Adj. EPS $3.33 vs $3.10 Est.; Sees Prelim. FY21 Sales $10.79B vs $10.56B Est. vs $ Est, Adj. EPS $14.24 vs $13.97 Est.   Benzinga
06:51AM EST  Quest Diagnostics Expects Q4 Revenue To Be About $2.74 Bln, Decrease Of 9% From Last Year   RTTNews
06:45AM EST  QUEST DIAGNOSTICS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2021   PR Newswire
Jan 11, 2022
01:11PM EST  Quest Diagnostics to Release Fourth Quarter and Full Year 2021 Financial   PR Newswire
10:44AM EST  'FDA Acting Commissioner Woodcock on rapid tests. There are now total of 15 authorized by FDA. New program in place to accelerate review of these tests.' -News Nation Reporter   Benzinga
Jan 10, 2022
03:44PM EST  US Health & Human Services Says, Starting Jan. 15, 2022, Individuals With Private Health Insurance/Group Health Plan Who Buy Over-The-Counter COVID Tests Will Have Costs Covered By Plan/Insurance   Benzinga
02:28PM EST  White House Says Expects To Have All Contracts For New Rapid Test Awarded Over Next 2 Weeks   Benzinga
Jan 5, 2022
09:43AM EST  Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $170   Benzinga
Jan 4, 2022
02:34PM EST  QUEST DIAGNOSTICS TO SPEAK AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE   PR Newswire
Dec 28, 2021
10:27AM EST  New York City To Double In-School PCR COVID Testing When Students Return   Benzinga
Dec 23, 2021
12:19PM EST  White House Still Working To Finalize Contracts For US Orders Of COVID Tests; COVID Testing Stocks Quiet   Benzinga
Dec 22, 2021
02:35PM EST  FDA Website Shows Dec. 22-Dated update On Antigen Tests For Omicron: 'The FDA continues to monitor and evaluate the impact of genetic variants on antigen tests...'   Benzinga
Dec 21, 2021
04:39PM EST  President Biden Tweets 'Starting this week, the federal government will set up emergency testing sites in areas that need additional testing capacity. Before Christmas, the first several of these federal testing sites will be up and running in New York..'   Benzinga
02:26PM EST  'Web site will be set up next month for any US household wanting to get free #coronavirus tests delivered, says @PressSec.' -Tweet   Benzinga
12:18PM EST  Fauci Says President Biden To Leverage Defense Production Act To Spur 200M To 500M COVID Tests To Market   Benzinga
12:17PM EST  New York Attorney General Issues Post 'Attorney General James Issues Warning to LabQ Diagnostics to Stop Misrepresenting Turnaround Times for COVID-19 Test Results'   Benzinga
Dec 20, 2021
02:43PM EST  'Senator Calls For Federal Marijuana Standard To Measure Impaired Driving' -Marijuana Moment Report   Benzinga
Dec 17, 2021
11:17AM EST  COVID Testing Plays Quiet Following Headline Biden Admin. Will Push For 'Test-To-Stay' Policy To Keep Kids In School   Benzinga
09:45AM EST  Morgan Stanley Maintains Equal-Weight on Quest Diagnostics, Lowers Price Target to $159   Benzinga
Dec 16, 2021
08:31AM EST  Quest Diagnostics Earns Gold Status in American Heart Association's 2021   PR Newswire
Dec 14, 2021
09:46AM EST  Price Over Earnings Overview: Quest Diagnostics   Benzinga
08:33AM EST  Quest Diagnostics (DGX) said that it has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory provider serving physicians and patients primarily in South and North Carolina, Georgia and Florida.   RTTNews
08:29AM EST  Quest Diagnostics Acquires South Carolina-Based Labtech Diagnostics; Terms not Disclosed   Benzinga
08:27AM EST  Quest Diagnostics Acquires South Carolina-based Labtech Diagnostics   PR Newswire
08:14AM EST  Wells Fargo Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $160   Benzinga
Dec 13, 2021
04:30AM EST  Keybanc Maintains Overweight on Quest Diagnostics, Raises Price Target to $170   Benzinga
Dec 9, 2021
09:42PM EST  'Senate votes to repeal key Biden administration vaccine and testing policy' -Earlier Washington Post Report   Benzinga
Dec 2, 2021
09:29AM EST  White House Chief Of Staff Ronald Klain Says President Biden Will Announce Today 'FREE and RELIABLE' COVID At Home Tests   Benzinga
Dec 1, 2021
08:49AM EST  Quest Diagnostics Now Offers Biocept's Liquid Biopsy Test For Lung Cancer   Benzinga
Nov 30, 2021
04:03PM EST  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Nov 17, 2021
07:00PM EST  Quest Diagnostics (DGX) Declares Quarterly Dividend of $ 0.62 , Record Date 1/19/2022   RTTNews
06:47PM EST  Quest Diagnostics Declares Quarterly Dividend Of $0.62/share, Payable Feb. 2/ Record Jan. 19   RTTNews
06:40PM EST  Quest Diagnostics Declares Quarterly Cash Dividend   PR Newswire
Nov 15, 2021
07:02AM EST  Majority of Physicians Worry Signs of Addiction Were Missed During Pandemic,   PR Newswire
Nov 12, 2021
01:36PM EST  Wall Street Crime And Punishment: The Blood On Elizabeth Holmes' Fingers   Benzinga
Nov 4, 2021
04:19PM EDT  Quest Diagnostics To Speak At The Credit Suisse 30(tm) Annual Healthcare   PR Newswire
Oct 26, 2021
12:39PM EDT  What 5 Analyst Ratings Have To Say About Quest Diagnostics   Benzinga
07:21AM EDT  Wells Fargo Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $150   Benzinga
Oct 21, 2021
12:36PM EDT  Quest Diagnostics shares were trading higher after the company reported better-than-expected Q3 EPS and sales results and raised FY21 EPS and sales guidance above estimates.   Benzinga
12:12PM EDT  Quest Diagnostics: Q3 Earnings Insights   Benzinga
12:12PM EDT  Quest Diagnostics Inc Says It Performed An Average Of 83,000 COVID-19 Molecular Tests A Day In The Third Quarter   Benzinga
12:11PM EDT  The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO   Benzinga
12:11PM EDT  Quest Diagnostics Raises FY21 EPS Guidance From $11.65-$12.35 To $13.50-$13.90 Vs. $11.93 Est., Sales From $9.84B-$10.09B To $10.45B-$10.60B Vs. $10B Est.   Benzinga
12:11PM EDT  Quest Diagnostics Q3 EPS $3.96 Beats $2.87 Estimate, Sales $2.77B Beat $2.45B Estimate   Benzinga
12:11PM EDT  Earnings Scheduled For October 21, 2021   Benzinga
07:03AM EDT  While reporting financial results for the second quarter on Thursday, Quest Diagnostics Inc. (DGX) raised its earnings, adjusted earnings and revenue guidance for the full-year 2021, to reflect higher than anticipated COVID-19 testing volumes and base business performance.   RTTNews
06:53AM EDT  Quest Diagnostics (DGX) released earnings for third quarter that dropped from the same period last year.   RTTNews
06:53AM EDT  Quest Diagnostics Q3 EPS $4.02; Adj EPS $3.96   RTTNews
06:47AM EDT  Quest Diagnostics Q3 Revenues Of $2.77 Bln, Down 0.4% From 2020   RTTNews
06:46AM EDT  Quest Diagnostics Reports Third Quarter 2021 Financial Results, Raises Outlook   PR Newswire
Oct 20, 2021
10:18AM EDT  Earnings Outlook For Quest Diagnostics   Benzinga
08:38AM EDT  Quest Diagnostics To Provide K-12 School COVID-19 Testing In Collaboration With Ginkgo Bioworks   RTTNews
08:38AM EDT  Quest Diagnostics Reports Deal With Texas Dept. Of State Health Services To Provide COVID-19 Kindergarten Through Grade 12 School Testing Services; Ginkgo Bioworks Will Provide Support Services   Benzinga
08:37AM EDT  Ginkgo Bioworks to Support Safer Classroom Learning in Texas for New Statewide School Testing Program   PR Newswire
Oct 19, 2021
09:52AM EDT  Price Over Earnings Overview: Quest Diagnostics   Benzinga
Oct 18, 2021
08:05AM EDT  Quest Diagnostics (DGX), on Monday, said it has decided to introduce clinical laboratory testing using Ki-67 IHC MIB-1 pharmDx (Dako Omnis) immunohistochemistry companion diagnostic.   RTTNews
07:34AM EDT  The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs   Benzinga
07:06AM EDT  Quest Diagnostics To Provide Clinical Laboratory Testing Using Ki-67 IHC MIB-1 pharmDx   Benzinga
07:03AM EDT  Quest Diagnostics To Introduce Ki-67 IHC MIB-1 PharmDx; To Make Testing Available Nationally By End Of Oct   RTTNews
07:02AM EDT  Diagnostic for Eli Lilly and Company's Verzenio(r) (abemaciclib), a CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer   PR Newswire
Oct 12, 2021
08:45AM EDT  Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Companys Chief Financial Officer (CFO). Mr. Kiboro will assume the responsibilities of CFO on November 1st, 2021, replacing Mr. Peter Buhler who will support the Company during the transitional phase, as needed, before leaving Quotient Limited at year-end.   GlobeNewswire Inc
06:53AM EDT  Quest Diagnostics Announces Next-Generation Lab Facility In Clifton, NJ   RTTNews
06:45AM EDT  Quest Diagnostics Debuts Next-Generation Lab Facility in Clifton, NJ   PR Newswire
Oct 8, 2021
04:23PM EDT  Quest Diagnostics 8-K Shows. Co. Subsidiary, ReproSource, Experienced Data Security Incident During Aug. In Which Unauthorized Party May Have Accessed, Acquired Protected Health Info, Personal Info From ReproSource Patients   Benzinga
Oct 5, 2021
08:34AM EDT  Quest Diagnostics To Be Exclusive Provider Of Onsite COVID-19 Testing For 125th Boston Marathon   Benzinga
08:32AM EDT  Quest Diagnostics, Boston Athletic Association Team Up To Provide Onsite COVID-19 Diagnostic Testing For Boston Marathon   RTTNews
08:31AM EDT  Quest Diagnostics and the Boston Athletic Association Team Up to Provide Onsite   PR Newswire
Oct 4, 2021
11:49AM EDT  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Sep 29, 2021
12:56PM EDT  Quest Diagnostics To Release Third Quarter 2021 Financial Results On October 21   PR Newswire
Sep 28, 2021
07:03AM EDT  Over Half of U.S. Children Have Detectable Levels of Lead in their Blood, Finds   PR Newswire
Sep 14, 2021
04:06PM EDT  Quest Diagnostics Says Evaluating Opportunities To Scale Lab Testing Capacity And Rapid Antigen Test Inventory Should COVID-19 Test Demand Increase; Says Has Performed And Reported Over 55.5M Molecular Diagnostic And Antibody Serology Tests Since 2020   Benzinga
04:04PM EDT  Quest Diagnostics Says Evaluating New Federal COVID-19 Action Plan, Potential Implications, Once Specific Requirements Are Included In Pending OSHA Rule   Benzinga
Sep 10, 2021
09:02AM EDT  Carnival Announces Pre-Board Testing Initiative To Facilitate Testing At 1,500 Quest Diagnostics Centers   Benzinga
08:00AM EDT  The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test   Benzinga
Sep 9, 2021
09:55AM EDT  Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests   Benzinga
08:17AM EDT  The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization   Benzinga
07:01AM EDT  Quest Diagnostics Incorporated (DGX) has updated its financial outlook for full year 2021. The company said COVID-19 molecular testing volumes were stronger than expected through the end of August and are anticipated to continue to be stronger than projected because of the surge of the Delta variant.   RTTNews
06:50AM EDT  Quest Diagnostics Raises FY21 EPS Guidance From $10.65-$11.35 To $11.65-$12.35 Vs. $11.38 Est., Sales From $9.54B-$9.79B To $9.84B-$10.09B Vs. $9.79B Est.   Benzinga
06:48AM EDT  Quest Diagnostics Lifts FY Revenues View To $9.84-$10.09 Bln   RTTNews
06:45AM EDT  Quest Diagnostics Updates Outlook For Full Year 2021   PR Newswire
Sep 8, 2021
07:32AM EDT  The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod   Benzinga
Sep 3, 2021
10:14AM EDT  Underwhelming: Tepid Jobs Data Could Add New Variable To Fed Policy Equation   Benzinga
07:31AM EDT  The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself   Benzinga
Sep 2, 2021
08:20AM EDT  The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab   Benzinga
Sep 1, 2021
07:45AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
04:34AM EDT  Keybanc Maintains Overweight on Quest Diagnostics, Raises Price Target to $168   Benzinga
Aug 31, 2021
11:20AM EDT  Cancer Diagnoses Declined Sharply During First Year of COVID-19 Pandemic, Finds   PR Newswire
07:55AM EDT  Morgan Stanley Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $165   Benzinga
Aug 30, 2021
11:19AM EDT  Quest Diagnostics to Speak at the Morgan Stanley 19th Annual Global Healthcare   PR Newswire
Aug 19, 2021
07:17AM EDT  Mizuho Maintains Buy on Quest Diagnostics, Raises Price Target to $166   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
04:12PM EDT  UPDATE: Quest Diagnostics Maintains 1-Day Turnaround Time for Majority Of Its COVID-19 Tests   Benzinga
04:11PM EDT  UPDATE: Quest Diagnostics Reports Cumulative Diagnostic (Molecular) COVID-19 Tests Performed 45.9M, Serology Tests 6.6M, Test Capacity Per Day 300K   Benzinga
04:10PM EDT  Quest Diagnostics Media Statement about COVID-19 Testing   Benzinga
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
06:48AM EDT  Quest Diagnostics Elects Tracey Doi To Board   RTTNews
06:45AM EDT  Quest Diagnostics Elects Tracey C. Doi to Board of Directors   PR Newswire
Aug 16, 2021
07:46PM EDT  Quest Diagnostics Declares Quarterly Dividend Of $0.62/share, Payable Oct. 20/ Record Oct. 5   RTTNews
06:30PM EDT  Quest Diagnostics Declares Quarterly Cash Dividend   PR Newswire
Aug 13, 2021
07:46AM EDT  Credit Suisse Maintains Neutral on Quest Diagnostics, Raises Price Target to $150   Benzinga
Aug 11, 2021
01:45PM EDT  Quest Diagnostics, eMed Team Up To Offer COVID-19 Rapid Antigen Testing At Workplaces   Benzinga
10:04AM EDT  Price To Earnings Ratio Insights For Quest Diagnostics   Benzinga
09:06AM EDT  Quest Diagnostics And eMed Announce Collaboration For eMed Certified Guide To Supervise Testing Process For BinaxNOW COVID-19 Ag Card Home Test   Benzinga
09:03AM EDT  eMed and Quest Diagnostics Collaborate to Offer   GlobeNewswire Inc
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Aug 3, 2021
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
Jul 22, 2021
11:34AM EDT  The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO   Benzinga
09:52AM EDT  Quest Diagnostics shares were trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also issued FY21 sales guidance above analyst estimates.   Benzinga
09:21AM EDT  Quest Q2 Earnings Ahead Of Expectation On Recovery Of Non-COVID Business, Issues Mixed FY21 Guidance   Benzinga
08:18AM EDT  The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO   Benzinga
07:12AM EDT  Quest Diagnostics: Q2 Earnings Insights   Benzinga
07:01AM EDT  While reporting financial results for the second quarter on Thursday, Quest Diagnostics Inc. (DGX) initiated its earnings, adjusted earnings and revenue guidance for the full-year 2021.   RTTNews
06:52AM EDT  Quest Diagnostics (DGX) announced earnings for its second quarter that rose from the same period last year.   RTTNews
06:46AM EDT  Quest Diagnostics Q2 EPS $4.96; Adj EPS $3.18   RTTNews
06:46AM EDT  Quest Diagnostics Reports Second Quarter 2021 Financial Results; Establishes   PR Newswire
06:45AM EDT  Quest Diagnostics Q2 EPS $3.18 Beats $2.86 Estimate, Sales $2.55B Beat $2.38B Estimate   Benzinga
04:02AM EDT  Earnings Scheduled For July 22, 2021   Benzinga
Jul 21, 2021
10:44AM EDT  Earnings Preview: Quest Diagnostics   Benzinga
10:38AM EDT  Quest Diagnostics's Earnings: A Preview   Benzinga
Jul 20, 2021
08:32AM EDT  CLX Health Announces Collaboration With Quest Diagnostics To Provide Access To COVID-19 Molecular Diagnostic Testing   RTTNews
08:31AM EDT  TrustAssure(tm) Announces Travel and Live Event Covid Testing through a   PR Newswire
Jul 14, 2021
11:36AM EDT  Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for   PR Newswire
Jul 12, 2021
10:16AM EDT  Quest Announces Program To Address Health Disparities Exacerbated By Delayed Treatment Or Diagnosis During COVID-19   RTTNews
10:12AM EDT  Sisters and Federally Qualified Health Centers Team Up to Address the Hidden Pandemic's Impact on Underserved Communities   PR Newswire
Jul 6, 2021
09:31AM EDT  Quest Diagnostics To Release Second Quarter 2021 Financial Results On July 22   PR Newswire
Jul 2, 2021
10:40AM EDT  Understanding Quest Diagnostics's Ex-Dividend Date   Benzinga
Jun 22, 2021
10:20AM EDT  Biocept Stock Moves Higher On Collaboration With Quest Diagnostics For Liquid Biopsy Testing For Lung Cancer Patients   Benzinga
Jun 21, 2021
06:50AM EDT  Quest Diagnostics Releases Annual Corporate Responsibility Report For 2020   RTTNews
06:45AM EDT  Quest Diagnostics Releases Annual Corporate Responsibility Report   PR Newswire
Jun 16, 2021
08:20AM EDT  The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO   Benzinga
06:34AM EDT  Epizyme Launches EZH2Now Testing Program With Quest Diagnostics For Relapsed Or Refractory Follicular Lymphoma Patients   Benzinga
Jun 14, 2021
09:57AM EDT  5 Value Stocks To Watch In The Healthcare Sector   Benzinga
Jun 7, 2021
09:42AM EDT  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Jun 1, 2021
04:12PM EDT  Quest Diagnostics Completes Acquisition Of Mercy's Outreach Laboratory Services Business   RTTNews
04:06PM EDT  Quest Diagnostics Completes Acquisition of Mercy's Outreach Laboratory Services   PR Newswire
May 26, 2021
09:04AM EDT  Keep Overall Drug Positivity Rates at Historically High Levels, Finds Latest Quest Diagnostics Drug Testing Index(tm) Analysis   PR Newswire
May 25, 2021
09:13AM EDT  Quest Diagnostics And Paige Announce Collaboration To 'Advance AI-generated Pathology Insights to Improve Cancer Diagnosis and Care'; Terms Not Disclosed   Benzinga
09:08AM EDT  Quest Diagnostics And Paige Announce Collaboration To Advance AI-generated Pathology Insights   RTTNews
09:05AM EDT  Quest Diagnostics and Paige Form Collaboration to Advance AI-generated   PR Newswire
May 24, 2021
07:06AM EDT  Social & Health Research Center and Quest Diagnostics Team Up to Address Childhood Hunger and Obesity Exacerbated by COVID-19 in Underserved Communities   Benzinga
07:01AM EDT  Childhood Hunger and Obesity Exacerbated by COVID-19 in Underserved Communities   PR Newswire
May 20, 2021
04:51PM EDT  Quest Diagnostics (DGX) Declares Quarterly Dividend of $ 0.62, Record Date 7/7/2021   RTTNews
04:12PM EDT  Quest Diagnostics Declares Quarterly Dividend Of $0.62/share, Payable July 21/ Record July 7   RTTNews
04:10PM EDT  Quest Diagnostics Declares Quarterly Cash Dividend   PR Newswire
May 19, 2021
02:54PM EDT  Quest Diagnostics To Speak At The Jefferies Virtual Healthcare Conference   PR Newswire
May 11, 2021
09:22AM EDT  Quest Diagnostics (DGX) on Tuesday unveiled several new enhancements to its COVID-19 testing services, with the goal to help combat COVID-19 while empowering more individuals and families to resume "back to life" activities with greater safety this spring, summer and beyond.   RTTNews
09:15AM EDT  Quest Diagnostics Reports Expansion Of Eligibility For $0 Out-Of-Pocket COVID-1 Testing Through QuestDirect   Benzinga
09:13AM EDT  Quest Diagnostics Highlights New 'Health Trends' Report Developed In Collab With CDC Showed COVID-19 Pandemic Reduced Routine Hep C Virus Testing, Treatment   Benzinga
09:07AM EDT  Quest Diagnostics Unveils Several New Enhancements To Its COVID-19 Testing Services   RTTNews
09:06AM EDT  Through QuestDirect(tm) To Assist in Combatting the Pandemic and Help Support Safer Travel, Events and Gatherings Nationwide   PR Newswire
08:02AM EDT  Reveals Concerning Decreases in Hepatitis C Testing and Treatment During First Months of COVID-19 Pandemic   PR Newswire
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 10, 2021
11:26AM EDT  Stocks That Hit 52-Week Highs On Monday   Benzinga
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
May 5, 2021
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
May 4, 2021
10:09AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021   Benzinga
08:10AM EDT  The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data   Benzinga
07:47AM EDT  10 Biggest Price Target Changes For Tuesday   Benzinga
07:23AM EDT  UBS Upgrades Quest Diagnostics to Buy, Raises Price Target to $158   Benzinga
May 3, 2021
09:06AM EDT  Ginkgo Bioworks Partners With Quest Diagnostics To Provide COVID-19 Kindergarten Through Senior School Testing Services   RTTNews
09:03AM EDT  Ginkgo Bioworks Teams with Quest Diagnostics to Provide COVID-19 Testing for   PR Newswire
09:02AM EDT  Ginkgo Bioworks And Quest Diagnostics To Provide K-12 COVID-19 Testing Services To Schools Nationwide   Benzinga
Apr 27, 2021
02:08PM EDT  Quest Diagnostics To Speak At BofA Securities 2021 Virtual Healthcare Conference   PR Newswire
Apr 22, 2021
12:21PM EDT  Earnings Scheduled For April 22, 2021   Benzinga
09:04AM EDT  Quest Diagnostics Says COVID Testing Has Ramped Down Faster Than Anticipated In Q1   Benzinga
08:09AM EDT  The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs   Benzinga
07:16AM EDT  Quest Diagnostics Inc. (DGX) said that it raised its earnings per share outlook for the first half of 2021 to range of $7.51 - $8.01 from the prior estimation of $5.07 - $6.07 per share.   RTTNews
07:14AM EDT  Recap: Quest Diagnostics Q1 Earnings   Benzinga
07:04AM EDT  Quest Diagnostics Raises First Half Sales Guidance From $4.85B-$5.15B To $5.00B-$5.20B   Benzinga
06:57AM EDT  Quest Diagnostics Q1 EPS $3.76 Beats $3.71 Estimate, Sales $2.72B Beat $2.64B Estimate   Benzinga
06:48AM EDT  Quest Diagnostics (DGX) announced a profit for its first quarter that increased from the same period last year.   RTTNews
06:47AM EDT  Quest Diagnostics Q1 EPS $3.46; Adj EPS $3.76   RTTNews
06:46AM EDT  Quest Diagnostics Reports First Quarter 2021 Financial Results; Announces Plan   PR Newswire
04:01AM EDT  Earnings Scheduled For April 22, 2021   Benzinga
Apr 13, 2021
08:03AM EDT  Testing at the 2021 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting   PR Newswire
08:00AM EDT  Quest Diagnostics Says Now Have Capacity To Perform Nearly 300,000 COVID-19 Molecular Diagnostic Tests A Day; Says Well Positioned To Expand COVID-19 Clinical Testing As Well As Industry 'Return To Life' Programs, Such As K-12 School Testing   Benzinga
Apr 7, 2021
05:19PM EDT  Quest Diagnostics To Release First Quarter 2021 Financial Results On April 22   PR Newswire
Apr 5, 2021
10:16AM EDT  Ex-Dividend Date Insight: Quest Diagnostics   Benzinga
Apr 1, 2021
09:37AM EDT  Quest Diagnostics Offloads Interest in Q2 Solutions JV To IQVIA   Benzinga
07:38AM EDT  IQVIA Holdings Inc. (IQV) announced the acquisition of the 40 percent minority share of Q2 Solutions from Quest Diagnostics (DGX), for $760 million, resulting in 100 percent ownership by IQVIA.   RTTNews
07:08AM EDT  IQVIA Acquires Remaining 40% Interest in Q2 Solutions from Quest Diagnostics For $760M   Benzinga
07:04AM EDT  IQVIA Acquires Remaining 40% Minority Share Of Q2 Solutions From Quest Diagnostics For $760 Mln   RTTNews
07:04AM EDT  Quest Diagnostics Sells Ownership Interest in Q Solutions to IQVIA   PR Newswire
Mar 30, 2021
08:13AM EDT  Quest Diagnostics Gives Statement Related To COVID-19 Testing In K-12 Schooling   Benzinga
Mar 16, 2021
04:11PM EDT  Quest Diagnostics Says Average Turnaround Time For COVID-19 Molecular Diagnostic Testing Continues To Be About 1-2 Days Across All Populations   Benzinga
Mar 15, 2021
09:08AM EDT  Zora Biosciences Signs Non-exclusive License Agreement With Quest Diagnostics   RTTNews
09:04AM EDT  Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics for   PR Newswire
Mar 12, 2021
09:51AM EST  Morgan Stanley Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $136   Benzinga
07:37AM EST  Baird Downgrades Quest Diagnostics to Neutral, Announces $137 Price Target   Benzinga
Mar 11, 2021
07:02AM EST  Ahead of its virtual meeting with analysts and investors at its Investor Day later on Thursday, Quest Diagnostics Inc. (DGX) reaffirmed its outlook for the first half of 2021.   RTTNews
06:53AM EST  Quest Diagnostics Announces Co. To Buyback $900M Of Its Shares In The First Half Of 2021   Benzinga
06:52AM EST  Quest Diagnostics Reiterates First Half of 2021 EPS Guidance of $5.90-$6.90, Sales Guidance of $4.85B-$5.15B   Benzinga
06:49AM EST  Quest Diagnostics Lifts Long-term View To 4-5% Revenue CAGR For Base Business And 7-9% Earnings CAGR For Total Company   RTTNews
06:45AM EST  Quest Diagnostics Updates Strategic Growth Drivers and Provides Long-Term   PR Newswire
Mar 8, 2021
09:09AM EST  Quest To Acquire Outreach Laboratory Services Business Of Mercy In An All-cash Asset Transaction   RTTNews
09:07AM EST  Quest Diagnostics and Mercy Broaden Access to Innovative, Convenient Lab   PR Newswire
Mar 2, 2021
09:01AM EST  98point6 to Provide Text-Based Virtual Care for Quest Diagnostics Employer   PR Newswire
08:45AM EST  Quest Diagnostics Says As Of March 2, Average Turnaround Time For COVID-19 Molecular Diagnostic Testing Continues To Be About 1-2 Days Across All Populations; Says Now Able To Perform As Many As 250K Tests A Day   Benzinga
Feb 25, 2021
07:03AM EST  Genalyte and Sonora Quest Laboratories Partner to Provide Predictive Analytics   PR Newswire
Feb 24, 2021
07:36AM EST  Quest Diagnostics Unveils New COVID-19 Semi-quantitative Serology Test Service   RTTNews
07:31AM EST  Quest Diagnostics Highlights Introduction Of New COVID-19 Semi-Quantitative Serology Test Service   Benzinga
07:31AM EST  Quest Diagnostics Introduces New COVID-19 Semi-quantitative Serology Test   PR Newswire
Feb 23, 2021
04:17PM EST  Quest Diagnostics Names Timothy Ring New Lead Independent Director   RTTNews
04:16PM EST  Quest Diagnostics Announces Board Leadership Changes   PR Newswire
08:34AM EST  GRAIL Announces Agreement With Quest Diagnostics To Provide Phlebotomy Services   RTTNews
08:30AM EST  GRAIL and Quest Diagnostics Announce Collaboration to Support Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test   Business Wire
06:20AM EST  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that Manuel Mendez has been appointed as Chief Executive Officer of the Company and will begin serving in that role on April 1st, 2021. Franz Walt, who has served as the companys CEO since 2018 is retiring.   GlobeNewswire Inc
Feb 16, 2021
12:52PM EST  Quest Diagnostics To Speak At Citi's 2021 Healthcare Services, Medtech, Tools &   PR Newswire
09:02AM EST  Quest Diagnostics Says COVID-19 Molecular Testing Now 'Faster Than At Any Other Time During Pandemic,' Says Average Turnaround Time ~One-To-Two Days Across All Populations With 'Vast Majority' Completed In One Day   Benzinga
06:50AM EST  EmblemHealth And Quest Diagnostics Renew Lab Services Relationship   Benzinga
06:46AM EST  EmblemHealth And Quest Diagnostics Renew Long-standing Strategic Relationship   RTTNews
Feb 9, 2021
03:30PM EST  Quest Diagnostics to Host Virtual Investor Day On March 11, 2021   PR Newswire
Feb 4, 2021
11:16AM EST  Quest Diagnostics shares were trading higher after the company reported better-than-expected Q4 EPS and sales results   Benzinga
08:49AM EST  Quest Diagnostics Inc Exec Says Expect Demand For COVID-19 Tests To Decline In 2021   Benzinga
08:46AM EST  Quest Diagnostics Exec Says Co, Performed Average Of 135,000 COVID-19 Tests A Day In Q4   Benzinga
08:35AM EST  Earnings Scheduled For February 4, 2021   Benzinga
07:26AM EST  Recap: Quest Diagnostics Q4 Earnings   Benzinga
07:22AM EST  The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs   Benzinga
06:56AM EST  Quest Diagnostics (DGX) announced a profit for its fourth quarter that climbed from last year.   RTTNews
06:47AM EST  Quest Diagnostics Q4 EPS From Cont Opns $4.21; Adj EPS $4.48   RTTNews
06:46AM EST  Quest Diagnostics Sees H1'21 Adj. EPS $5.90-$6.90, Sales $4.85B-$5.15B   Benzinga
06:46AM EST  Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results;   PR Newswire
06:45AM EST  Quest Diagnostics Q4 Adj. EPS $4.48 Beats $4.24 Estimate, Sales $3.00B Beat $2.93B Estimate   Benzinga
06:42AM EST  Quest Diagnostics Incorporated (DGX) said its Board of Directors has increased the company's share repurchase authorization by $1 billion. The increased authority is in addition to the $917 million that was available as of December 31, 2020 under the share repurchase program.   RTTNews
06:41AM EST  Quest Diagnostics (DGX) Announces $1 Bln Stock Buyback   RTTNews


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC